Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 4 Nov 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores TCGX Acquisition Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (72): Smaller than most of the companies we track.
Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on TCGX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
TCGX appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Higher than 32% of US stocks
Higher than 30% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
TCGX Acquisition Corp. has a market value of $113.5M and an enterprise value of $0.0.
Forward dividend yield: 0.00%.
TCGX Acquisition Corp. employs 0 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own TCGX Acquisition Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
TriGemX Bio and TCGX Acquisition Corp. announced that they confidentially submitted a draft Form S-4 registration statement to the SEC in connection with their proposed business combination.
Why it matters — The submission is a step in the proposed business combination involving TCGX.
As at 4 Nov 2026, TCGX Acquisition Corp. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (72 of 100).
No analyst covering TCGX Acquisition Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TCGX are extrapolating price history, which says nothing about the business.
TCGX Acquisition Corp. Class A Ordinary Shares represents the public equity of a special purpose acquisition company, or SPAC, formed to pursue a merger, share exchange, asset acquisition, or similar business combination with one or more businesses.
The most recent item we track (Business Wire, 2 Nov 2026): "TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination". TriGemX Bio and TCGX Acquisition Corp. announced that they confidentially submitted a draft Form S-4 registration statement to the SEC in connection with their proposed business combination.
TCGX Acquisition Corp. Class A Ordinary Shares represents the public equity of a special purpose acquisition company, or SPAC, formed to pursue a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. TCGX Acquisition Corp. is based in Palo Alto, California, and operates as a blank check company within the financial services sector. Its shares are used as a vehicle for public investors to participate in the company’s search for a target operating business. The company’s structure is designed to provide capital market access for a future combination transaction, with a particular focus on healthcare and healthcare-related industries, including life sciences and medical technology. As a recently listed SPAC, TCGX Acquisition Corp. plays a transitional role in the market, linking private companies seeking a public listing with investors looking for exposure to merger-driven corporate combinations.
CEO Dr. Chen-Ming Yu M.B.A., M.D. · United States · https://tcgcrossover.com
